El ácido folínico no es eficaz en el tratamiento del síndrome de Kearns-Sayre | Neurología (Barc., Ed. impr.);34(5): 347-347, jun. 2019. | IBECS

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

El ácido folínico no es eficaz en el tratamiento del síndrome de Kearns-Sayre / Folinic acid is ineffective for treating kearns-sayre síndrome

Finsterer, J; Maeztu, C.

Affiliation

Finsterer, J; Krankenanstalt Rudolfstiftung. Viena. Austria
Maeztu, C; General Hospital. Division of Neurology. España

Neurología (Barc., Ed. impr.) ; 34(5): 347-347, jun. 2019.

Article in Es | IBECS | ID: ibc-180855

Responsible library: ES1.1

Localization: BNCS

RESUMEN

RESUMEN

No disponible

Subject(s)

Humans; Male; Child; Leucovorin/therapeutic use; Kearns-Sayre Syndrome/drug therapy; Treatment Outcome; Gene Deletion; Kearns-Sayre Syndrome/genetics

Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Kearns-Sayre Syndrome / Leucovorin Limits: Child / Humans / Male Language: Es Journal: Neurología (Barc., Ed. impr.) Year: 2019 Document type: Article

Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Kearns-Sayre Syndrome / Leucovorin Limits: Child / Humans / Male Language: Es Journal: Neurología (Barc., Ed. impr.) Year: 2019 Document type: Article